Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kosuke KASHIWABARA
Ki-1 (CD30)-positive Anaplastic Large Cell Lymphoma, Sarcomatoid Variant Accompanied by Spontaneously Regressing Lymphadenopathy.
Internal Medicine
Internal Medicine
Medicine
Analgesic-Induced Asthma Caused by 2.0% Ketoprofen Adhesive Agents, but Not by 0.3% Agents.
Internal Medicine
Internal Medicine
Medicine
Related publications
Ki-1 Large Cell Lymphoma With Regressing Lesions in a Child
Pediatric Dermatology
Dermatology
Child Health
Pediatrics
Perinatology
Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Primary Systemic CD30 (Ki-1)-Positive Anaplastic Large Cell Lymphoma of the Adult: Sequential Intensive Treatment With the F-Machop Regimen (+/- Radiotherapy) and Autologous Bone Marrow Transplantation
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma. A Series of Nine Cases
Gaceta Medica de Mexico
Medicine
Enteropathy-Associated Anaplastic Large T Cell Lymphoma ALK-positive (EA-ALCL-ALK+): Variant of T Cell Lymphoma With Possible Two-Hit Pathogenesis
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Intravascular ALK-Positive Anaplastic Large-Cell Lymphoma Mimicking Inflammatory Breast Carcinoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Anti-Cd30 Antibody Conjugated Liposomal Doxorubicin With Significantly Improved Therapeutic Efficacy Against Anaplastic Large Cell Lymphoma
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Primary Cutaneous Anaplastic Large Cell Lymphoma
Journal of Cutaneous Pathology
Dermatology
Forensic Medicine
Pathology
Histology
